Long-QT syndrome induced by the antiaddiction drug ibogaine

New England Journal of Medicine

Volumn 360, Issue 3, 2009, Pages 308-309

  Hoelen, Dianne W M ^a   Spiering, Wilko ^a   Valk, Gerlof D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IBOGAINE;

ADULT; ALCOHOLISM; CASE REPORT; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LETTER; LONG QT SYNDROME; PRIORITY JOURNAL; QT PROLONGATION; SINGLE DRUG DOSE;

EID: 58349122266     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0804248     Document Type: Letter

References (5)

1. He D-Y, McGough NNH, Ravindranathan A, et al. Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J Neurosci 2005;25:619-28.
2. Vastag B. Addiction treatment strives for legitimacy. JAMA 2002;288:3096, 3099-101.
3. Idem. Addiction research - ibogaine therapy: a 'vast, uncontrolled experiment.' Science 2005;308:345-6. [Erratum, Science 2005;308:1260.]
4. Lotsof HS, Wachtel B. Manual for ibogaine therapy: screening, safety, monitoring & aftercare. Second revision. The Ibogaine Dossier, 2003. (Accessed December 22, 2008, at http://www.ibogaine.org/manual.html.)
5. Maas U, Strubelt S. Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction. Med Hypotheses 2006;67:960-4.